Pharmaceutical Executive

Pharmaceutical Executive: October 2025
Volume: 45
Issue: 8

Pharmaceutical Executive: September 2025
Volume: 45
Issue: 7

Pharmaceutical Executive: August 2025
Volume: 45
Issue: 6

Pharmaceutical Executive: June 2025
Volume: 45
Issue: 5

Pharmaceutical Executive: May 2025
Volume: 45
Issue: 4

Pharmaceutical Executive: April 2025
Volume: 45
Issue: 3

Pharmaceutical Executive: March 2025
Volume: 45
Issue: 2

Pharmaceutical Executive: February 2025
Volume: 45
Issue: 1

Pharmaceutical Executive: December 2024
Volume: 44
Issue: 12

Pharmaceutical Executive: November 2024
Volume: 44
Issue: 11

Pharmaceutical Executive: October 2024
Volume: 44
Issue: 10

Pharmaceutical Executive: September 2024
Volume: 44
Issue: 9

Pharmaceutical Executive: July/August 2024
Volume: 44
Issue: 7/8

Pharmaceutical Executive: June 2024
Volume: 44
Issue: 6

Pharmaceutical Executive: May 2024
Volume: 44
Issue: 5

Pharmaceutical Executive: April 2024
Volume: 44
Issue: 4

Pharmaceutical Executive: March 2024
Volume: 44
Issue: 3

Pharmaceutical Executive: February 2024
Volume: 44
Issue: 1

Pharmaceutical Executive: December 2023
Volume: 43
Issue: 12

Pharmaceutical Executive: November 2023
Volume: 43
Issue: 11

Pharmaceutical Executive: October 2023
Volume: 43
Issue: 10

Pharmaceutical Executive: September 2023
Volume: 43
Issue: 9

Pharmaceutical Executive: August 2023
Volume: 43
Issue: 8

Pharmaceutical Executive: July 2023
Volume: 43
Issue: 7

Pharmaceutical Executive: June 2023
Volume: 43
Issue: 6

Pharmaceutical Executive: May 2023
Volume: 43
Issue: 5

Pharmaceutical Executive: April 2023
Volume: 43
Issue: 4

Pharmaceutical Executive: March 2023
Volume: 43
Issue: 3

Pharmaceutical Executive: February 2023
Volume: 43
Issue: 02

Pharmaceutical Executive: January 2023
Volume: 43
Issue: 01
Advertisement
Advertisement
Trending on PharmExec
1
Bob Mauch: Strengthening the Chain
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Novo Nordisk Announces Major Shake Ups to Board
4
The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations
5